Table G25Policy interventions: economic outcomes

Author, Year
N in Each Group
Outcome
Source
Results
Choudhry et al., 201131
G1: 2845
G2: 3010
Total insurer spending
(US dollars)
Health claims records
Mean (SD)
G1: 64,726 (639,683)
G2: 69,997 (617,650)
Relative Spending (95% CI): 0.92 (0.55–1.56)
Total patient spending
(US dollars)
Health claims records
G1: 1,282 (1,549)
G2: 1,781 (2,263)
Relative Spending (95% CI): 0.74 (0.68–0.80)
Combined insurer and patient total spending
(US dollars)
Health claims records
G1: 66,008 (639,970)
G2: 71,778 (618,055)
Relative Spending (95% CI): 0.89 (0.50–1.56)

Abbreviations: G = group; N = number; NA = not applicable; CI = confidence interval; ACE Inhibitor = angiotensin-converting-enzyme inhibitor; ARBs = angiotensin-receptor blockers; HR = hazard ratio

From: Appendix G, Patient, Provider, and Policy Interventions: Summary Evidence Tables

Cover of Closing the Quality Gap: Revisiting the State of the Science (Vol. 4: Medication Adherence Interventions: Comparative Effectiveness)
Closing the Quality Gap: Revisiting the State of the Science (Vol. 4: Medication Adherence Interventions: Comparative Effectiveness).
Evidence Reports/Technology Assessments, No. 208.4.
Viswanathan M, Golin CE, Jones CD, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.